Clinical Trial

RETHINK REFLUX Registry

Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
The RETHINK REFLUX Registry is a post-market prospective, multi-center, observation, single arm, long-term safety surveillance registry of subjects implanted with the LINX device. The primary objective of the study is to confirm the long-term safety profile of the LINX device and procedure (implant/explant) up to 10 years post-implant.
Protocol Amendment History 72 amendments
This ClinicalTrials.gov record has been amended 72 times since 2020-01-31; most recent amendment 2026-07-02.
Status change: Recruiting → Active, Not Recruiting 2023-08-14
Status change: Not Yet Recruiting → Recruiting 2020-07-21
Trial Details
NCT Number NCT04253392
Lead Sponsor Ethicon Endo-Surgery
Conditions Gastroesophageal Reflux
Enrollment 500 participants
Start Date 2020-07-08
Primary Completion 2032-07-31 (estimated)
Study Completion 2032-07-31 (estimated)
Updated on ClinicalTrials.gov 2026-07-06